Searchable abstracts of presentations at key conferences in endocrinology

ea0063p954 | Diabetes, Obesity and Metabolism 3 | ECE2019

Doege-potter syndrome in patients with malignant extrapleural solitary fibrous tumor: a single center experience

Peiro Inmaculada , Iglesias Pedro , Diez Juan Jose , Martin-Liberal Juan , Garcia-del-Muro Xavier , Serrano Teresa , Villabona Carles

Introduction: Doege-Potter syndrome (DPS) is a rare paraneoplastic syndrome consistent in non-islet-cell tumor hypoglycemia associated with solitary fibrous tumor (SFT). Pathogenesis of hypoglycemia has been attributed to the production of insulin-like growth-factor-2 (IGF-2) by tumor cells. We report two DPS patients with metastatic extrapleural SFT.Case 1: A 42-year-old man with SFT of the mesocolon that had been operated in 2010, presented with metast...

ea0056p118 | Endocrine tumours and neoplasia | ECE2018

Comparative study between familial and sporadic pheochromocytoma

Garcia-Sancho Paula , Marengo Agustina P. , Guerrero Fernando , Peiro Inmaculada , Santacruz Elisa , Jose Diez Juan , Iglesias Pedro , Villabona Carles

Introduction: Pheochromocytomas (Pheo) may appear sporadically (SPheo) or as an autosomal dominant inherited disease, named as familial PHEOs (FPheo). The latter are present in younger patients, and usually with multiple tumors, but may occur in patients with apparently simple sporadic tumors with no other syndromic features.Material and methods: Clinical data of all consecutive patients underwent surgery for Pheo over 35 years in two tertiary referral c...

ea0049ep88 | Adrenal medulla | ECE2017

Pheochromocytoma in neurofibromatosis type 1

Marengo Agustina Pia , Garcia-Sancho Paula , Guerrero Fernando , Peiro Inmaculada , Santacruz Elisa , Ortiz Andres , Diez Juan Jose , Iglesias Pedro , Villabona Carles

Background: Individuals with neurofibromatosis type-1 (NF1) carry an increased risk of pheochromocytoma (PHEO). Detection strategy is unknown but most experts recommend screening if hypertension develops.Objective: Report the characteristics of PHEO in patients with NF1 (NF1 group) and compare them with non-NF1-associated PHEO (non-NF1 group).Methods: Retrospective cohort study of patients undergoing PHEO resection in two Spanish t...

ea0056gp46 | Adrenal medulla and NETs | ECE2018

Comparative study between incidental and symptomatic pheochromocytoma

Santacruz Elisa , Ortiz-Flores Andres , Diez Juan Jose , Pian Hector , Marengo Agustina P , Garcia-Sancho Paula , Peiro Inmaculada , Villabona Carles , Iglesias Pedro

Introduction: The widespread use of abdominal computed tomography and magnetic resonance imaging has led to a rise in the diagnosis of incidental adrenal lesions, some of them are pheochromocytomas (Pheo).Objective: To investigate the differences between incidental (IPheo) and symptomatic Pheo (SPheo).Methods: A multicenter retrospective study on clinical and pathological characteristics, treatment and outcome in patients with Pheo...

ea0056p114 | Endocrine tumours and neoplasia | ECE2018

Are there any clinical predictor for malignancy in malignant pheochromocytoma?

Pia Marengo Agustina , Garcia-Sancho Paula , Guerrero Perez Fernando , Peiro Inmaculada , Santacruz Elisa , Ortiz Flores Andres , Jose Diez Juan , Iglesias Pedro , Villabona Carles

Introduction: Malignant pheochromocytoma (MPheo) is diagnosed by the presence of invasion of adjacent structures or distant metastasis. Predictive factors of malignancy for pheochromocytoma (Pheo) are not well known.Material and methods: We retrospectively analyzed clinical, biochemical, radiological characteristics as predictors for malignancy in patients with Pheo in two Spanish tertiary hospitals during the past 35 years. We also evaluated time of rec...

ea0090p111 | Endocrine-related Cancer | ECE2023

Body composition of Patients with advanced Gastroenteropancreatic (GEP) Neuroendocrine Neoplasms (NENs) in Spain: Nutrigetne Study

Argente Pla Maria , Casteras Anna , Giribes Miguel , Anton Beatriz , Soledad Librizzi Maria , Custodio Carretero Ana , Palma Milla Samara , Suarez Gutierrez Lorena , Peiro Inmaculada , Serrano Urzaiz Leticia , Leon-Idougourram Soraya , Dieguez Felechosa Marta , Febrero Beatriz , Scorojanu Iulia , Antonio Pazos Toral Fernando , Biarnes Josefina , Pascual-Corrales Eider , Angel Dias-Perez Jose , Antonio Sampedro-Nunez Miguel , Angel Martinez Olmos Miguel , Mico Garcia Andrea , Isabel Del Olmo Garcia Maria

Introduction / Background: Patients with advanced GEP-NENs often present with metabolic disorders and oncological treatments may increase malnutrition risk as well as alterations on body composition. Several studies have suggested that sarcopenia is independently associated with a worse prognosis in oncological patients. Sarcopenia predicts survival regardless of body weight; moreover, a reduced muscle mass is not only observed in cachectic individuals but also in overweight p...